The specificity of SCF ubiquitin ligase-mediated protein degradation is determined by F-box proteins 1,2 . We identified a biplanar dicarboxylic acid compound, called SCF-I2, as an inhibitor of substrate recognition by the yeast F-box protein Cdc4 using a fluorescence polarization screen to monitor the displacement of a fluorescein-labeled phosphodegron peptide. SCF-I2 inhibits the binding and ubiquitination of full-length phosphorylated substrates by SCF Cdc4 . A co-crystal structure reveals that SCF-I2 inserts itself between the -strands of blades 5 and 6 of the WD40 propeller domain of Cdc4 at a site that is 25 Å away from the substrate binding site. Longrange transmission of SCF-I2 interactions distorts the substrate binding pocket and impedes recognition of key determinants in the Cdc4 phosphodegron. Mutation of the SCF-I2 binding site abrogates its inhibitory effect and explains specificity in the allosteric inhibition mechanism. Mammalian WD40 domain proteins may exhibit similar allosteric responsiveness and hence represent an extensive class of druggable target.
l e t t e r s
The specificity of SCF ubiquitin ligase-mediated protein degradation is determined by F-box proteins 1, 2 . We identified a biplanar dicarboxylic acid compound, called SCF-I2, as an inhibitor of substrate recognition by the yeast F-box protein Cdc4 using a fluorescence polarization screen to monitor the displacement of a fluorescein-labeled phosphodegron peptide. SCF-I2 inhibits the binding and ubiquitination of full-length phosphorylated substrates by SCF Cdc4 . A co-crystal structure reveals that SCF-I2 inserts itself between the -strands of blades 5 and 6 of the WD40 propeller domain of Cdc4 at a site that is 25 Å away from the substrate binding site. Longrange transmission of SCF-I2 interactions distorts the substrate binding pocket and impedes recognition of key determinants in the Cdc4 phosphodegron. Mutation of the SCF-I2 binding site abrogates its inhibitory effect and explains specificity in the allosteric inhibition mechanism. Mammalian WD40 domain proteins may exhibit similar allosteric responsiveness and hence represent an extensive class of druggable target.
The ubiquitin-proteasome system mediates the intracellular degradation of many proteins through a cascade of enzyme activities, termed E1, E2 and E3, which serially activate and then transfer ubiquitin to substrate proteins 3 . E3 enzymes, also referred to as ubiquitin ligases, specifically recognize discrete sequence motifs in substrates termed degrons. The human genome encodes at least 600 E3 enzymes, each of which has the potential to recognize multiple substrates 4 . The largest class of E3 enzymes, the cullin-RING ligases, were discovered through identification of the multi-subunit Skp1-Cdc53/Cullin-F-box protein (SCF) complexes 1, 2 . A large family of F-box proteins recruit substrates to the core SCF complex by means of protein interaction domains, typically leucinerich repeats or WD40 repeats, often in a phosphorylation-dependent manner 1, 2, [5] [6] [7] . The SCF enzymes likely target hundreds of different substrates 4, [8] [9] [10] and thus hold untapped potential for drug discovery 4 .
The WD40 repeat is an ancient conserved motif that functions in many different cellular processes 11, 12 . Tandem arrays of five to eight WD40 repeats form a circularly permuted β-propeller domain structure 13 . In yeast, recognition of the cyclin-dependent kinase (CDK) inhibitor Sic1 by the WD40 domain of the F-box protein Cdc4 depends on phosphorylation of multiple Cdc4 phosphodegron (CPD) motifs in Sic1 (refs. 6, 14) . SCF Cdc4 also targets other substrates including Far1, Cdc6 and Gcn4 (ref. 1). Human CDC4, also known as FBW7, recruits a number of important regulatory factors for ubiquitination including cyclin E, MYC, JUN, NOTCH, SREBP and presenilin 9 . FBW7 is a haploinsufficient tumor suppressor that is mutated in many cancer types 9, 15 and also likely influences stem cell renewal by virtue of its effects on MYC and other factors 16 . Given the central role of Cdc4/FBW7 in growth and division, we sought to identify small molecules that inhibit substrate recognition by Cdc4.
We adapted a previously established fluorescence polarization assay to monitor the displacement of a fluorescein-labeled CPD peptide (K d ≈ 0.2 μM) from yeast Cdc4 (Supplementary Fig. 1a ) 14 . The fluorescence polarization assay achieved a Z-factor of 0.8, based on negative (DMSO solvent only) and positive (unlabeled CPD peptide) controls. A screen against a 50,000-compound library enriched for drug-like molecules 17 yielded 44 hits that inhibited the CPD-Cdc4 interaction by at least 50% (Fig. 1a) . Two of these compounds, denoted SCF-I2 and SCF-I6, strongly inhibited the interaction of full-length phospho-Sic1 with Cdc4 and prevented Sic1 ubiquitination by SCF Cdc4 (Fig. 1b) . We pursued only SCF-I2 because SCF-I6 appeared to cause nonspecific loss of Skp1-Cdc4 complex from the capture resin (Fig. 1b) . SCF-I2 corresponds to 1-(2-carboxynaphth-1yl)-2-naphthoic acid, which is a derivative of 1,1′-binapthyl-2,2′diol, also known as BINOL, a biplanar axially chiral atropisomer that is widely used as a scaffold in chiral synthesis 18 . The two hydroxyl groups of BINOL are substituted by carboxylic acid groups in SCF-I2 (Fig. 1c) . The form of 1-(2-carboxynaphth-1-yl)-2-naphthoic acid) used in all of our assays was an undefined racemic mixture of the R-and S-enantiomers, which are noninterconvertible at even high temperature 18 . SCF-I2 was tenfold less potent than unlabeled CPD peptide in the fluorescence polarization assay, with an IC 50 of 6.2 μM versus 0.5 μM, respectively (Fig. 1c) . SCF-I2 inhibited binding and/or ubiquitination of both full-length Sic1 and Far1 with an IC 50 of ~60 μM (Supplementary Fig. 1b,c) ; the weaker apparent affinity of SCF-I2 in these assays may reflect differences in the interaction of peptides and full-length substrates with Cdc4. SCF-I2 failed to inhibit Cdc4 activity in vivo (data not shown), presumably because the two carboxylate groups prevented efficient partitioning of the inhibitor into yeast cells. SCF-I2 did not affect the in vitro activity of the closely related E3 enzyme SCF Met30 , which recruits its substrate Met4 by means of the WD40 domain of the F-box protein Met30 (Supplementary Fig. 1d ) 19 .
We determined the crystal structure of SCF-I2 bound to a Skp1-Cdc4 complex 20 to 2.6 Å resolution (see Supplementary Table 1 for data collection and refinement statistics). Unbiased difference electron-density maps revealed that SCF-I2 binds to the WD40 repeat domain of Cdc4 at a site that is 25 Å distant from the CPD binding pocket (Fig. 2a) . The eight WD40 repeat motifs of Cdc4 form a canonical propeller structure in which each propeller blade consists of four anti-parallel β-strands and intervening loop regions (Supplementary Fig. 2 ) 20 . SCF-I2 embeds itself in a deep pocket on the lateral surface of the β-propeller between blades 5 and 6 (Fig. 2a,b and Supplementary Fig. 2 ). Cdc4 engages only one of two enantiomers of SCF-I2, the (R)-(+) equivalent of BINOL. The top naphthalene ring system of SCF-I2 inserts itself deeply between blades 5 and 6, forming extensive hydrophobic contacts with Leu628, Ile594, Leu634, Trp657 and Ala649 (Fig. 2b) . In addition, the carboxyl group of the top ring system hydrogen bonds to the NH group of the Trp657 side chain and forms a salt bridge with the side chain of Arg664. The bottom naphthalene ring system is more exposed to solvent and forms a stabilizing co-planar stacking interaction with the side chain of Arg664 and van der Waals interactions with the side chains of Ser667 and Arg655. The carboxyl group of the bottom ring system also forms ionic interactions with the side chains of Arg655 and His631.
In the apo-Skp1-Cdc4 structure, there is no obvious preexisting pocket that might anticipate the binding mode of SCF-I2 (Fig. 2c) . Rather, the SCF-I2 binding pocket is induced by separation of blades 5 and 6 and a drastic shift of the β21-β22 linker that connects the two blades (Fig. 2d) . The reorientation of the β21-β22 linker entails a 5 Å shift of the main chain and a massive 13 Å shift of the side chain of His631 from a buried to a solvent-exposed position (Fig. 2d,e) . These large conformational alterations create an interblade void that is filled by the rearrangement of residues proximal to the CPD binding pocket (Fig. 2d,e) . The void is filled in part by a swap of side chain positions between Val635, which is normally buried and adjacent to His631 and the normally solventexposed Leu634 side chain; as a consequence of this rearrangement, the side chains of Val635 and Leu634 traverse 6 and 8 Å, respectively. The position vacated by Leu634 in turn is filled by rotation of the side chain of Tyr574. Critically, both Tyr574 and Leu634 constitute part of the highly conserved CPD binding infrastructure. In the CPD peptide-Skp1-Cdc4 complex 20 , Tyr574 and Leu634 line the hydrophobic P-2 binding pocket within the central pore ( Fig. 2e) and thereby dictate the preference for hydrophobic residues at the P-2 position of the CPD consensus motif 14, 20 . The P-2 pocket is thus severely distorted by the reoriented side chains of Tyr574 and Leu634 in the SCF-I2 bound structure. In addition, the hydroxyl group of Tyr574 participates in stabilizing H-bond interactions with the side chain of Arg572, one of the four invariant essential arginine residues found in all Cdc4 orthologs 20 . Arg572 stabilizes the orientation of Tyr548, which in turn directly hydrogen-bonds to the CPD phosphate group in the P0 position. Thus, SCF-I2 critically compromises the main binding pockets for the P-2 and P0 positions of the CPD consensus sequence 14, 20 . As predicted by this structural model, the effects of SCF-I2 are mimicked by a Tyr574Ala mutation, which results in a 20-fold reduction in the affinity of Cdc4 for the CPD peptide (Fig. 2f) .
We explored the determinants of the SCF-I2-Cdc4 interface. The two carboxylic acid groups of SCF-I2 exhibit marked charge complementarity with the guanidinium side chains of Arg655 and Arg664. Mutation of each arginine residue individually to alanine attenuated the inhibition of Cdc4 by SCF-I2 by at least 50-fold (Fig. 2g) . Alleles bearing either mutation fully complemented Cdc4 function in vivo, indicating that this region of Cdc4 is not normally critical in substrate recognition or SCF catalytic activity ( Supplementary  Fig. 3a) . To investigate the structural features of SCF-I2 required for Cdc4 inhibition, we tested a panel of available BINOL analogs for activity in the fluorescence polarization assay ( Supplementary  Fig. 3b,c) . This series demonstrated the importance of the naphthalene ring systems that participate in numerous hydrophobic interactions and the carboxylate groups that form electrostatic interactions with the two arginine residues on Cdc4. These mutational and structure-activity results validate the binding mode for SCF-I2 observed in the crystal structure.
We next assessed the activity SCF-I2 toward human FBW7. The key Cdc4 residues Arg655 and Arg664 are replaced in FBW7 by lysine l e t t e r s and cysteine, respectively, suggesting that FBW7 might be resistant to inhibition by SCF-I2. This proved to be the case as SCF-I2 inhibited the CPD-FBW7 interaction only at high concentrations (Fig. 3a) . The residual inhibitory activity of SCF-I2 toward FBW7 might be due to the conservative Arg-to-Lys substitution and the conservation of most other residues that form the induced SCF-I2 binding pocket ( Fig. 3b and Supplementary Fig. 2) . Alignment of all human WD40 domains revealed that, aside from the two surface arginine residues, the pattern of SCF-I2 contact residues is often conserved (Supplementary Fig. 4) . We are currently exploring whether the BINOL scaffold can be modified to more potently interact with FBW7 and other human WD40 domain proteins.
The most thoroughly studied WD40 domain proteins are the β subunits of heterotrimeric G proteins, which transduce signals from a host of G protein-coupled receptors 21 . Notably, the interaction of the regulatory protein phosducin with the G t β subunit of the heterotrimeric G-protein transducin also causes substantial structural rearrangements between adjacent WD propeller blades 22 . These rearrangements induce a binding pocket for the C-terminal farnesyl moiety of the partner G t γ subunit, which may serve to regulate membrane association of the G t βγ complex 22 . Comparison of our SCF-I2-Cdc4 structure and the phosducin-G t βγ structure reveals three highly similar features. First, the ligand-bound forms of both structures exhibit an analogous buried-to-exposed transition of the conserved histidine residue at the apex of the connector between the affected blades (Fig. 3c) . Second, the Cdc4 and G t β structures show a close juxtaposition of induced binding pockets for the SCF-I2 and farnesyl ligands, respectively (Fig. 3c) . Third, these rearrangements l e t t e r s occur between blades 5 and 6 for both WD40 structures. That two functionally unrelated and evolutionarily distant proteins undergo similar induced conformational changes hints that allosteric responsiveness may be an intrinsic and conserved feature of the WD40 domain. In contrast to conventional protein interaction inhibitors that directly block the substrate binding site, such as the p53-MDM2 inhibitor nutlin 23 , SCF-I2 elicits its effect by an allosteric mechanism. A structural feature of WD40 domains and other β-propeller structures such as the Kelch domain is the variability in blade number, which in known WD40 structures ranges from five to eight blades per domain 13 . The circular β-propeller structure can exhibit interblade separation 24 and structural tolerance to artificial insertion of an additional repeat 25 . WD40 domains may thus be inherently susceptible to disruption by insertion of appropriately configured small molecules between adjacent blades. Although it remains to be determined whether all WD40 domains exhibit allosteric responsiveness, in other protein families ultraconserved residues can transmit long-range allosteric effects 26 .
To our knowledge, SCF-I2 represents the first example of a WD40 domain inhibitor. As our data with Cdc4 and FBW7 show, allosteric inhibition can discriminate between even highly related domains that recognize identical substrate motifs; thus, it may be feasible to design other inhibitors that are selective for particular WD40 domain proteins. Moreover, allosteric inhibitors may be combined with conventional binding pocket inhibitors to increase potency 27 . The yeast genome encodes at least 113 proteins with WD40 or WD40-like domains that function in signaling, transcription, chromatin remodeling, mRNA splicing, DNA replication and repair, protein synthesis, the ubiquitin system, autophagy, vesicle trafficking, the cytoskeleton and organelle biogenesis (Supplementary Table 2 ). In humans, WD40 domains occur in at least 256 different proteins and perform similarly diverse functions (Supplementary Table 3) . Biomedically important WD40 domain proteins include the F-box proteins FBW7 and β-TrCP 8 , target of rapamycin kinase complex subunits 28 and Gβ-subunits of heterotrimeric G proteins 21, 27 . Our findings suggest that the WD40 domain may be generally accessible to allosteric modulation by small molecules.
MeThoDS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturebiotechnology/. Top displays a superposition of Cdc4 (blue) bound to SCF-I2 (yellow) with the G t β subunit (dark green) bound to bovine retinal phosducin (pink) and a farnesyl ligand (magenta) from an associated G t γ subunit (PDB: 1A0R). Bottom displays a superposition of unliganded forms of Cdc4 (gray) and the G t β subunit (light green) (PDB: 1TBG). For illustrative purposes, SCF-I2 and farnesyl ligands from the top image have been modeled into the lower image. 30 . Ubiquitination of Met4 by SCF Met30 was carried out as described 19 .
SCF-I2 -
X-ray structure determination. Crystals of Skp1-Cdc4 263-744 were derived as described previously 20 . Crystals were transferred to buffer containing 100 mM Tris (pH 8.5), 1.5 M ammonium sulfate, 15% glycerol and 1 mM 1-(2-carboxynaphth-1-yl)-2-naphthoic acid (SCF-I2) and incubated at 23 °C for 30 min to incorporate SCF-I2 into the crystal lattice and to cryoprotect the crystal. Soaked crystals retained the same space group of P3 2 (a = 108.281, b = 108.281, c = 165.594, α = β = 90°, γ = 120°). All structural methods were carried out essentially as described previously 20 . High-resolution data were collected on a frozen crystal at the Advanced Photon Source on beamline BM-14C (λ = 0.9 Å) using a Quantum ADSC CCD detector. Data were processed using the HKL program suite 31 . The structure was solved by molecular replacement using PDB 1NEX as the search model in CNS 32 and model building in O 33 . Geometric parameters and restraints for SCF-I2 were determined in HIC-UP 34 and used in the refinement.
Final rounds of refinement were carried out in Refmac 35 . The structure was refined to 2.6 Å to a working R value of 21.1% and R free of 26.3% (Supplementary Table 1 ).
Bioinformatic analysis of WD40 repeat domain proteins. Yeast WD40 repeat domains listed in Supplementary Table 2 were extracted manually from the Saccharomyces Genome Database (http://www.yeastgenome.org/), based on matches to the Interpro database using the Interpro scan (iprscan) program 36 .
Interpro collates motif and domain information from the PROSITE, PRINTS, Pfam, ProDom, SMART, TIGERFAMs, PIR SUPERFAMILY, Gene3D and PANTHER databases 37 . Human WD40 repeat domain proteins were identified by scanning human annotated proteins from UniProt 38 using a hidden Markov model approach 39 for the presence of the WD40 repeat domain. 255 significant matches to WD40 repeats were obtained (Supplementary Table 3 ). Gene and protein annotations were obtained from the above databases and condensed into unified designations. We then used amino acid residues contacting SCF-I2 to define a perfect match search pattern, which was then modified to allow gaps within loop regions between WD40 β-strands and conserved amino acid substitutions. Regions containing the best matches to the query pattern were aligned using Probcons 40 . Human WD40 repeat domain proteins that contain a putative SCF-I2 binding pocket are listed in Supplementary Figure 4 .
